PMID- 24863668 OWN - NLM STAT- MEDLINE DCOM- 20150209 LR - 20220318 IS - 1558-1497 (Electronic) IS - 0197-4580 (Linking) VI - 35 IP - 10 DP - 2014 Oct TI - Iron overload accelerates neuronal amyloid-beta production and cognitive impairment in transgenic mice model of Alzheimer's disease. PG - 2288-301 LID - S0197-4580(14)00321-2 [pii] LID - 10.1016/j.neurobiolaging.2014.04.019 [doi] AB - Iron dyshomeostasis is proving increasingly likely to be involved in the pathology of Alzheimer's disease (AD); yet, its mechanism is not well understood. Here, we investigated the AD-related mechanism(s) of iron-sulfate exposure in vitro and in vivo, using cultured primary cortical neurons and APP/PS1 AD-model mice, respectively. In both systems, we observed iron-induced disruptions of amyloid precursor protein (APP) processing, neuronal signaling, and cognitive behavior. Iron overload increased production of amyloidogenic KPI-APP and amyloid beta. Further, this APP misprocessing was blocked by MK-801 in vitro, suggesting the effect was N-methyl-D-aspartate receptor (NMDAR) dependent. Calcium imaging confirmed that 24 hours iron exposure led to disrupted synaptic signaling by augmenting GluN2B-containing NMDAR expression-GluN2B messenger RNA and protein levels were increased and promoting excessing extrasynaptic NMDAR signaling. The disrupted GluN2B expression was concurrent with diminished expression of the splicing factors, sc35 and hnRNPA1. In APP/PS1 mice, chronic iron treatment led to hastened progression of cognitive impairment with the novel object recognition discrimination index, revealing a deficit at the age of 4 months, concomitant with augmented GluN2B expression. Together, these data suggest iron-induced APP misprocessing and hastened cognitive decline occur through inordinate extrasynaptic NMDAR activation. CI - Copyright (c) 2014 Elsevier Inc. All rights reserved. FAU - Becerril-Ortega, Javier AU - Becerril-Ortega J AD - INSERM, U836, BP 170, Grenoble Cedex 9, F-38042, France; Universite Joseph Fourier, Grenoble Institut des Neurosciences, BP 170, Grenoble Cedex 9, F-38042, France. FAU - Bordji, Karim AU - Bordji K AD - Universite de Caen-Basse Normandie, GIP Cyceron, CNRS UMR 6301 ISTCT, CERVOxy Group, Caen, France. FAU - Freret, Thomas AU - Freret T AD - GMPc-EA4259, Universite de Caen Basse-Normandie, GIP Cyceron 14032, Caen, France. FAU - Rush, Travis AU - Rush T AD - INSERM, U836, BP 170, Grenoble Cedex 9, F-38042, France; Universite Joseph Fourier, Grenoble Institut des Neurosciences, BP 170, Grenoble Cedex 9, F-38042, France. FAU - Buisson, Alain AU - Buisson A AD - INSERM, U836, BP 170, Grenoble Cedex 9, F-38042, France; Universite Joseph Fourier, Grenoble Institut des Neurosciences, BP 170, Grenoble Cedex 9, F-38042, France. Electronic address: alain.buisson@ujf-grenoble.fr. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140501 PL - United States TA - Neurobiol Aging JT - Neurobiology of aging JID - 8100437 RN - 0 (Amyloid beta-Peptides) SB - IM MH - Alzheimer Disease/*metabolism/*psychology MH - Amyloid beta-Peptides/*metabolism MH - Animals MH - Cells, Cultured MH - Cerebral Cortex/cytology MH - *Cognition MH - Cognition Disorders/*etiology MH - Disease Models, Animal MH - HEK293 Cells MH - Humans MH - Iron Overload/*complications/*metabolism/*psychology MH - Mice, Inbred C57BL MH - Mice, Transgenic MH - Neurons/*metabolism OTO - NOTNLM OT - Alzheimer's disease OT - Amyloid beta OT - GluN2B OT - Iron OT - NMDA OT - Transgenic mouse EDAT- 2014/05/28 06:00 MHDA- 2015/02/11 06:00 CRDT- 2014/05/28 06:00 PHST- 2013/07/09 00:00 [received] PHST- 2014/04/14 00:00 [revised] PHST- 2014/04/22 00:00 [accepted] PHST- 2014/05/28 06:00 [entrez] PHST- 2014/05/28 06:00 [pubmed] PHST- 2015/02/11 06:00 [medline] AID - S0197-4580(14)00321-2 [pii] AID - 10.1016/j.neurobiolaging.2014.04.019 [doi] PST - ppublish SO - Neurobiol Aging. 2014 Oct;35(10):2288-301. doi: 10.1016/j.neurobiolaging.2014.04.019. Epub 2014 May 1.